|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.380 USD | +3.03% |
|
-2.46% | +32.22% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 192M | - | - | |||
| 1,051B | |||||
| 609B | |||||
| 450B | |||||
| 330B | |||||
| 284B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
